Non-interventional Study on Quality of Life, Efficacy and Tolerability of Nab-paclitaxel/Gemcitabine Firstline Therapy in Patients With Metastatic Pancreatic Cancer
Phase of Trial: Phase IV
Latest Information Update: 05 Jun 2018
At a glance
- Drugs Gemcitabine (Primary) ; Paclitaxel (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Acronyms QoliXane/PARAGON
- 05 Jun 2018 Interim results (n=601) presented at the 54th Annual Meeting of the American Society of Clinical Oncology
- 12 Sep 2017 Interim efficacy results (n=539) presented at the 42nd European Society for Medical Oncology Congress.
- 11 Oct 2016 Interim results (n=25) presented at the 41st European Society for Medical Oncology Congress.